Diogo Garcia

Dr. Diogo Garcia


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Neurosurgery
Verified
Journal Article
Closed access
DGDiogo Garcia
Diogo Garcia
OAOluwaseun O. Akinduro
Oluwaseun O. Akinduro
GBGaetano De Biase
Gaetano De Biase
BSBernardo Sousa-Pinto
Bernardo Sousa-Pinto
DJDaniel J. Jerreld
Daniel J. Jerreld
KAKingsley O. Abode-Iyamah
Kingsley O. Abode-Iyamah
BACKGROUND: Management of degenerative disease of the spine has evolved to favor minimally invasive techniques, including nonrobotic-assisted and robotic-assisted minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Value-based spending is being increasingly implemented to control rising costs in the US healthcare system. With an aging population, it is fundamental to understand which procedure(s) may be most cost-effective. OBJECTIVE: To compare robotic and nonrobotic MIS-TLIF through a cost-utility analysis. METHODS: We considered direct medical costs related to surgical intervention and to the hospital stay, as well as 1-yr utilities. We estimated costs by assessing all cases involving adults undergoing robotic surgery at a single institution and an equal number of patients undergoing nonrobotic surgery, matched by demographic and clinical characteristics. We adopted a willingness to pay of $50 000/quality-adjusted life year (QALY). Uncertainty was addressed by deterministic and probabilistic sensitivity analyses. RESULTS: Costs were estimated based on a total of 76 patients, including 38 undergoing robot-assisted and 38 matched patients undergoing nonrobot MIS-TLIF. Using point estimates, robotic surgery was projected to cost $21 546.80 and to be associated with 0.68 QALY, and nonrobotic surgery was projected to cost $22 398.98 and to be associated with 0.67 QALY. Robotic surgery was found to be more cost-effective strategy, with cost-effectiveness being sensitive operating room/materials and room costs. Probabilistic sensitivity analysis identified robotic surgery as cost-effective in 63% of simulations. CONCLUSION: Our results suggest that at a willingness to pay of $50 000/QALY, robotic-assisted MIS-TLIF was cost-effective in 63% of simulations. Cost-effectiveness depends on operating room and room (admission) costs, with potentially different results under distinct neurosurgical practices.

22 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
GBGaetano De Biase
Gaetano De Biase
SCSelby Chen
Selby Chen
EZEndrit Ziu
Endrit Ziu
DGDiogo Garcia
Diogo Garcia
EBElird Bojaxhi
Elird Bojaxhi
KAKingsley O. Abode-Iyamah
Kingsley O. Abode-Iyamah

18 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
BFBrin Freund
Brin Freund
SGSanjeet S. Grewal
Sanjeet S. Grewal
EMErik Middlebrooks
Erik Middlebrooks
DGDiogo Garcia
Diogo Garcia
AFAnteneh M. Feyissa
Anteneh M. Feyissa
WTWilliam O. Tatum
William O. Tatum

30 December 2023 in Current Treatment Options in Oncology
Verified
Journal Article
Closed access
PDF file
WSWendy J. Sherman
Wendy J. Sherman
EREdoardo Romiti
Edoardo Romiti
LMLoizos Michaelides
Loizos Michaelides
DGDiogo Garcia
Diogo Garcia
KCKaisorn L. Chaichana
Kaisorn L. Chaichana
APAlyx B. Porter
Alyx B. Porter

Verified
Journal Article
Open access
PDF file
JFJoão Augusto Freitas
João Augusto Freitas
IGIrene Gullo
Irene Gullo
DGDiogo Garcia
Diogo Garcia
Sara MirandaSara Miranda
Sara Miranda
LSLouisa Spaans
Louisa Spaans
JMJose Carlos Machado
Jose Carlos Machado
Background. The tumor immune microenvironment exerts a pivotal influence in tumor initiation and progression. The aim of this study was to analyze the immune context of sporadic and familial adenomatous polyposis (FAP) lesions along the colorectal adenoma–carcinoma sequence (ACS). Methods. We analyzed immune cell counts (CD3+, CD4+, CD8+, Foxp3+, and CD57+), tumor mutation burden (TMB), MHC-I expression and PD-L1 expression of 59 FAP and 74 sporadic colorectal lesions, encompassing adenomas with low-grade dysplasia (LGD) (30 FAP; 30 sporadic), adenomas with high-grade dysplasia (22 FAP; 30 sporadic), and invasive adenocarcinomas (7 FAP; 14 sporadic). Results. The sporadic colorectal ACS was characterized by (1) a stepwise decrease in immune cell counts, (2) an increase in TMB and MHC-I expression, and (3) a lower PD-L1 expression. In FAP lesions, we observed the same patterns, except for an increase in TMB along the ACS. FAP LGD lesions harbored lower Foxp3+ T cell counts than sporadic LGD lesions. A decrease in PD-L1 expression occurred earlier in FAP lesions compared to sporadic ones. Conclusions. The colorectal ACS is characterized by a progressive loss of adaptive immune infiltrate and by the establishment of a progressively immune cold microenvironment. These changes do not appear to be related with the loss of immunogenicity of tumor cells, or to the onset of an immunosuppressive tumor microenvironment.

1 June 2022 in World Neurosurgery
Verified
Journal Article
Closed access
DGDiogo Garcia
Diogo Garcia
BSBernardo Sousa-Pinto
Bernardo Sousa-Pinto
GBGaetano De Biase
Gaetano De Biase
HRHenry Ruiz-Garcia
Henry Ruiz-Garcia
OAOluwaseun O. Akinduro
Oluwaseun O. Akinduro
SCSelby Chen
Selby Chen